Mylan Inc. has successfully completed the divestment of its entire 5.64% equity stake in Biocon Limited. This significant transaction, valued at ₹3,679 crore, was executed through the screen-based trading platforms of both the BSE Limited and the National Stock Exchange of India, marking a full exit from Biocon for Mylan.
JSA Advocates & Solicitors’ Role
Jefferies India, one of the brokerage firms involved in facilitating this major stake sale, was represented by the esteemed law firm JSA Advocates & Solicitors. The advisory team was led by Partners Arka Mookerjee and Pracheta Bhattacharya, alongside Principal Associate Arjun Rastogi. Their legal expertise played a crucial role in the seamless execution of this transaction.
TT&A’s Contribution
Citigroup Global Markets India, the other broker involved, was advised by the reputable law firm TT&A. The legal team from TT&A was spearheaded by Partner Abhinav Kumar, with significant contributions from Managing Associate Shubham Sancheti and Senior Associate Abhishek Iyer. Their strategic guidance ensured the transaction’s compliance with legal and regulatory frameworks.
International Legal Counsel
In addition to domestic legal advisors, Citigroup Global Markets India also engaged the services of the international law firm Baker & McKenzie. Their involvement provided a global perspective to the legal proceedings, further safeguarding the interests of all parties involved.
This strategic exit by Mylan Inc. marks a notable event in the pharmaceutical sector, reflecting the dynamic nature of equity markets and the pivotal role of legal expertise in facilitating complex transactions.
More Read
For legal professionals and industry watchers keen on publishing their deals or insights, Bar & Bench invites submissions through their designated form, providing a platform for sharing legal developments and achievements.
